SUZHOU MEDICALSYSTEM TECHNOLOGY CO., LTD. Financials Suzhou MedicalSystem Technology Co., Ltd.
Equities
603990
CNE100002ZY8
Renewable Energy Equipment & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.19 CNY | +0.99% |
|
-3.65% | -36.61% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 2,619 | 3,857 | 4,678 | 3,634 | 4,044 | 3,918 |
| Enterprise Value (EV) 1 | 2,554 | 3,837 | 3,906 | 3,074 | 3,236 | 4,904 |
| P/E ratio | 47.6 x | 82.9 x | 134 x | 85.7 x | 119 x | -14.7 x |
| Yield | 0.64% | 0.37% | 0.21% | - | - | - |
| Capitalization / Revenue | 9.21 x | 11.6 x | 15.2 x | 10.3 x | 13.2 x | 6.34 x |
| EV / Revenue | 8.99 x | 11.5 x | 12.7 x | 8.69 x | 10.6 x | 7.93 x |
| EV / EBITDA | 44.1 x | 54.7 x | 62.9 x | 54.1 x | 69.9 x | -25.3 x |
| EV / FCF | -96.7 x | -222 x | 99.5 x | 2,002 x | 209 x | 69.2 x |
| FCF Yield | -1.03% | -0.45% | 1.01% | 0.05% | 0.48% | 1.44% |
| Price to Book | 5.34 x | 6.62 x | 4.27 x | 3.32 x | 3.28 x | 3.58 x |
| Nbr of stocks (in thousands) | 245,159 | 244,205 | 246,064 | 275,684 | 275,684 | 303,244 |
| Reference price 2 | 10.68 | 15.79 | 19.01 | 13.18 | 14.67 | 12.92 |
| Announcement Date | 3/29/19 | 4/24/20 | 4/16/21 | 4/29/22 | 4/28/23 | 4/29/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 284.3 | 333.1 | 308.1 | 353.8 | 305.5 | 618.1 |
| EBITDA 1 | 57.96 | 70.1 | 62.15 | 56.84 | 46.27 | -194 |
| EBIT 1 | 46.4 | 56.75 | 48.04 | 43.83 | 33.3 | -218.9 |
| Operating Margin | 16.32% | 17.04% | 15.59% | 12.39% | 10.9% | -35.41% |
| Earnings before Tax (EBT) 1 | 60.44 | 53.92 | 48.57 | 51.34 | 43.56 | -262 |
| Net income 1 | 55.48 | 46.89 | 35.44 | 41.95 | 33.56 | -269.4 |
| Net margin | 19.52% | 14.08% | 11.5% | 11.86% | 10.99% | -43.59% |
| EPS 2 | 0.2243 | 0.1905 | 0.1420 | 0.1538 | 0.1231 | -0.8800 |
| Free Cash Flow 1 | -26.41 | -17.3 | 39.27 | 1.536 | 15.45 | 70.85 |
| FCF margin | -9.29% | -5.19% | 12.75% | 0.43% | 5.06% | 11.46% |
| FCF Conversion (EBITDA) | - | - | 63.19% | 2.7% | 33.38% | - |
| FCF Conversion (Net income) | - | - | 110.8% | 3.66% | 46.03% | - |
| Dividend per Share 2 | 0.0683 | 0.0578 | 0.0391 | - | - | - |
| Announcement Date | 3/29/19 | 4/24/20 | 4/16/21 | 4/29/22 | 4/28/23 | 4/29/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | 986 |
| Net Cash position 1 | 64.8 | 20 | 772 | 561 | 808 | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | -5.084 x |
| Free Cash Flow 1 | -26.4 | -17.3 | 39.3 | 1.54 | 15.4 | 70.9 |
| ROE (net income / shareholders' equity) | 12.1% | 9.61% | 4.8% | 3.72% | 2.89% | -21.6% |
| ROA (Net income/ Total Assets) | 4.32% | 4.8% | 2.63% | 1.93% | 1.41% | -4.93% |
| Assets 1 | 1,285 | 976.6 | 1,347 | 2,170 | 2,373 | 5,460 |
| Book Value Per Share 2 | 2.000 | 2.380 | 4.450 | 3.970 | 4.470 | 3.610 |
| Cash Flow per Share 2 | 0.7100 | 0.7200 | 3.290 | 1.160 | 2.910 | 1.570 |
| Capex 1 | 16.6 | 12.9 | 8.88 | 41 | 24.6 | 600 |
| Capex / Sales | 5.85% | 3.87% | 2.88% | 11.58% | 8.05% | 97.04% |
| Announcement Date | 3/29/19 | 4/24/20 | 4/16/21 | 4/29/22 | 4/28/23 | 4/29/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -36.61% | 343M | |
| +35.38% | 24.97B | |
| -9.69% | 16.24B | |
| -38.08% | 14.82B | |
| -30.60% | 10.79B | |
| -16.48% | 10.21B | |
| +10.48% | 7.41B | |
| -35.00% | 5.67B | |
| -9.86% | 5.66B | |
| -44.95% | 4.8B |
- Stock Market
- Equities
- 603990 Stock
- Financials Suzhou MedicalSystem Technology Co., Ltd.
